Alzheimer’s disease (AD) and related dementias present significant challenges in therapeutic development, particularly within ...
In recent years, the field of oncology has increasingly acknowledged cancer as a metabolic disorder with significant ...
Nearly 50 new cancer therapies are approved every year. While this positive trend is a huge benefit for patients, Altuna Akalin, PhD, head of the bioinformatics and omics data science technology ...
Nectin-4 and Trop-2 expression as potential therapeutic target in collecting duct carcinoma: Preliminary results from the CICERONE trial (NCT05372302). This is an ASCO Meeting Abstract from the 2025 ...
The integration of multi-omics approaches in drug discovery is rapidly gaining momentum, offering a more comprehensive understanding of disease biology and paving the way for personalized medicine. A ...
Artificial Intelligence–Powered Human Epidermal Growth Factor Receptor 2 Quantification and Clinical Outcomes in Human Epidermal Growth Factor Receptor 2–Positive Biliary Tract Cancer Treated With ...
Colorectal cancer is among the most prevalent and lethal malignancies worldwide, with liver metastases occurring in nearly one-third of patients and accounting for a major share of cancer-related ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, Inc., a spatial multi-omics innovator accelerating biological discovery and new drug development, today announced that it will present new spatial ...
Dietrich A. Stephan, Ph.D., Executive Chair, Enhanced Genomics, said: “I am thrilled to welcome Katerina as the newest member ...
A groundbreaking review in Biological Diversity proposes a proactive, AI - integrated approach to stop biological invasions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback